Bisindolylmaleimide IX Facilitates Tumor Necrosis Factor Receptor Family-mediated Cell Death and Acts as an Inhibitor of Transcription
Open Access
- 6 September 2002
- journal article
- Published by Elsevier BV
- Vol. 277 (36), 33213-33219
- https://doi.org/10.1074/jbc.m204612200
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaPThe Prostate, 2002
- Phorbol 12-myristate 13-Acetate Inhibits Death Receptor-mediated Apoptosis in Jurkat Cells by Disrupting Recruitment of Fas-associated Polypeptide with Death DomainPublished by Elsevier BV ,2002
- Bcl-2 oncoprotein protects the human prostatic carcinoma cell line PC3 from TRAIL-mediated apoptosisOncogene, 2001
- Expression of c-FLIPL and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimideBlood, 2000
- p53 is involved in tumor necrosis factor-α-induced apoptosis in the human prostatic carcinoma cell line LNCaPOncogene, 2000
- Fas Ligand-independent, FADD-mediated Activation of the Fas Death Pathway by Anticancer DrugsPublished by Elsevier BV ,1999
- Inhibition of RNA polymerase II as a trigger for the p53 responseOncogene, 1999
- Bisindolylmaleimide VIII facilitates Fas-mediated apoptosis and inhibits T cell-mediated autoimmune diseasesNature Medicine, 1999
- Inhibitors of Transcription, Proteasome Inhibitors, and DNA-Damaging Drugs Differentially Affect Feedback of p53 DegradationExperimental Cell Research, 1998
- Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restrictionJournal of Medicinal Chemistry, 1993